Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.

Kim ES, Roy UB, Ersek JL, King J, Smith RA, Martin N, Martins R, Moore A, Silvestri GA, Jett J.

J Thorac Oncol. 2019 Mar;14(3):338-342. doi: 10.1016/j.jtho.2019.01.002. Epub 2019 Jan 30. No abstract available.

PMID:
30709747
2.

Principled Lung Cancer Screening Follows Screening Principles.

Mazzone PJ, Jett J.

Chest. 2018 Dec;154(6):1265-1266. doi: 10.1016/j.chest.2018.08.1056. No abstract available.

PMID:
30526961
3.

Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens.

Sakata KK, Midthun DE, Mullon JJ, Kern RM, Nelson DR, Edell ES, Schiavo DN, Jett JR, Aubry MC.

Chest. 2018 Oct;154(4):827-837. doi: 10.1016/j.chest.2018.07.017. Epub 2018 Jul 27.

PMID:
30059678
4.

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.

Bonomi PD, Gandara D, Hirsch FR, Kerr KM, Obasaju C, Paz-Ares L, Bellomo C, Bradley JD, Bunn PA Jr, Culligan M, Jett JR, Kim ES, Langer CJ, Natale RB, Novello S, Pérol M, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Vansteenkiste JF, Wakelee H, Thatcher N.

Ann Oncol. 2018 Aug 1;29(8):1701-1709. doi: 10.1093/annonc/mdy196.

5.

Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.

Edelsberg J, Weycker D, Atwood M, Hamilton-Fairley G, Jett JR.

PLoS One. 2018 May 22;13(5):e0197826. doi: 10.1371/journal.pone.0197826. eCollection 2018.

6.

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

Hirsch FR, Kerr KM, Bunn PA Jr, Kim ES, Obasaju C, Pérol M, Bonomi P, Bradley JD, Gandara D, Jett JR, Langer CJ, Natale RB, Novello S, Paz-Ares L, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Stinchcombe TE, Vansteenkiste JF, Wakelee H, Thatcher N.

Clin Lung Cancer. 2018 Jul;19(4):331-339. doi: 10.1016/j.cllc.2018.03.014. Epub 2018 Mar 21. Review.

7.

Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease.

Niska JR, Schild SE, Rule WG, Daniels TB, Jett JR.

Clin Lung Cancer. 2018 Jul;19(4):e417-e420. doi: 10.1016/j.cllc.2018.02.003. Epub 2018 Feb 17. No abstract available.

PMID:
29526532
8.

Corrigendum to "Tooth damage in captive orcas (Orcinus orca)" [Arch. Oral Biol. 84 (2017) 151-160].

Jett J, Visser IN, Ventre J, Waltz J, Loch C.

Arch Oral Biol. 2018 May;89:93. doi: 10.1016/j.archoralbio.2018.02.015. Epub 2018 Feb 27. No abstract available.

PMID:
29494811
9.

Cannabis Use, Lung Cancer, and Related Issues.

Jett J, Stone E, Warren G, Cummings KM.

J Thorac Oncol. 2018 Apr;13(4):480-487. doi: 10.1016/j.jtho.2017.12.013. Epub 2018 Jan 31. Review.

10.

Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors.

Brown LM, Cooke DT, Jett JR, David EA.

Ann Thorac Surg. 2018 Jan;105(1):207-213. doi: 10.1016/j.athoracsur.2017.07.049. Epub 2017 Nov 11.

PMID:
29132704
11.

Tooth damage in captive orcas (Orcinus orca).

Jett J, Visser IN, Ventre J, Waltz J, Loch C.

Arch Oral Biol. 2017 Dec;84:151-160. doi: 10.1016/j.archoralbio.2017.09.031. Epub 2017 Sep 29. Erratum in: Arch Oral Biol. 2018 Feb 26;89:93.

PMID:
28992601
12.

Scientific Advances in Thoracic Oncology 2016.

Soo RA, Stone ECA, Cummings KM, Jett JR, Field JK, Groen HJM, Mulshine JL, Yatabe Y, Bubendorf L, Dacic S, Rami-Porta R, Detterbeck FC, Lim E, Asamura H, Donington J, Wakelee HA, Wu YL, Higgins K, Senan S, Solomon B, Kim DW, Johnson M, Yang JCH, Sequist LV, Shaw AT, Ahn MJ, Costa DB, Patel JD, Horn L, Gettinger S, Peters S, Wynes MW, Faivre-Finn C, Rudin CM, Tsao A, Baas P, Kelly RJ, Leighl NB, Scagliotti GV, Gandara DR, Hirsch FR, Spigel DR.

J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1. Review.

13.

Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortex.

Jett JD, Bulin SE, Hatherall LC, McCartney CM, Morilak DA.

Neuroscience. 2017 Mar 27;346:284-297. doi: 10.1016/j.neuroscience.2017.01.017. Epub 2017 Jan 26.

14.

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).

Schild SE, Hillman SL, Tan AD, Ross HJ, McGinnis WL, Garces YA, Graham DL, Adjei AA, Jett JR; Mayo Clinic, North Central Cancer Treatment Group.

J Thorac Oncol. 2017 Apr;12(4):697-703. doi: 10.1016/j.jtho.2016.12.021. Epub 2017 Jan 12.

15.

A blood test for early detection of lung cancer.

Peek LJ, Jett JR.

MLO Med Lab Obs. 2016 Dec;48(12):18, 21. No abstract available.

PMID:
30047661
16.

Screening for Lung Cancer. Improving Outcomes with Better Patient Selection.

Vachani A, Jett JR.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):478-9. doi: 10.1164/rccm.201510-2096ED. No abstract available.

PMID:
26930429
17.

Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.

Mazzone PJ, Wang XF, Lim S, Choi H, Jett J, Vachani A, Zhang Q, Beukemann M, Seeley M, Martino R, Rhodes P.

BMC Cancer. 2015 Dec 23;15:1001. doi: 10.1186/s12885-015-1996-0.

18.

Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium.

Birse CE, Lagier RJ, FitzHugh W, Pass HI, Rom WN, Edell ES, Bungum AO, Maldonado F, Jett JR, Mesri M, Sult E, Joseloff E, Li A, Heidbrink J, Dhariwal G, Danis C, Tomic JL, Bruce RJ, Moore PA, He T, Lewis ME, Ruben SM.

Clin Proteomics. 2015 Jul 16;12(1):18. doi: 10.1186/s12014-015-9090-9. eCollection 2015.

19.

An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.

Slatore CG, Horeweg N, Jett JR, Midthun DE, Powell CA, Wiener RS, Wisnivesky JP, Gould MK; ATS Ad Hoc Committee on Setting a Research Framework for Pulmonary Nodule Evaluation.

Am J Respir Crit Care Med. 2015 Aug 15;192(4):500-14. doi: 10.1164/rccm.201506-1082ST.

20.

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.

Walling D, Marder SR, Kane J, Fleischhacker WW, Keefe RS, Hosford DA, Dvergsten C, Segreti AC, Beaver JS, Toler SM, Jett JE, Dunbar GC.

Schizophr Bull. 2016 Mar;42(2):335-43. doi: 10.1093/schbul/sbv072. Epub 2015 Jun 12.

21.

Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.

Jett JD, Boley AM, Girotti M, Shah A, Lodge DJ, Morilak DA.

Psychopharmacology (Berl). 2015 Sep;232(17):3123-33. doi: 10.1007/s00213-015-3957-3. Epub 2015 May 20.

22.

Progress in the development of volatile exhaled breath signatures of lung cancer.

Mazzone PJ, Wang XF, Lim S, Jett J, Choi H, Zhang Q, Beukemann M, Seeley M, Martino R, Rhodes P.

Ann Am Thorac Soc. 2015 May;12(5):752-7. doi: 10.1513/AnnalsATS.201411-540OC.

23.

How long does it take a cell to divide?

Jett JH.

Cytometry A. 2015 May;87(5):383-4. doi: 10.1002/cyto.a.22665. Epub 2015 Mar 26. No abstract available.

24.

MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.

Ak G, Tomaszek SC, Kosari F, Metintas M, Jett JR, Metintas S, Yildirim H, Dundar E, Dong J, Aubry MC, Wigle DA, Thomas CF Jr.

Biomed Res Int. 2015;2015:635748. doi: 10.1155/2015/635748. Epub 2015 Feb 1.

25.

The attentional set shifting task: a measure of cognitive flexibility in mice.

Heisler JM, Morales J, Donegan JJ, Jett JD, Redus L, O'Connor JC.

J Vis Exp. 2015 Feb 4;(96). doi: 10.3791/51944.

26.
27.

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G.

Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.

28.

RiboVision suite for visualization and analysis of ribosomes.

Bernier CR, Petrov AS, Waterbury CC, Jett J, Li F, Freil LE, Xiong X, Wang L, Migliozzi BL, Hershkovits E, Xue Y, Hsiao C, Bowman JC, Harvey SC, Grover MA, Wartell ZJ, Williams LD.

Faraday Discuss. 2014;169:195-207. doi: 10.1039/c3fd00126a. Epub 2014 May 28.

PMID:
25340471
29.

Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs).

Strachan JP, Kombo DC, Mazurov A, Heemstra R, Bhatti BS, Akireddy R, Murthy S, Miao L, Jett JE, Speake J, Bencherif M.

Eur J Med Chem. 2014 Oct 30;86:60-74. doi: 10.1016/j.ejmech.2014.08.019. Epub 2014 Aug 7.

PMID:
25147147
30.

Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial S0220.

Kernstine KH, Moon J, Kraut MJ, Pisters KM, Sonett JR, Rusch VW, Thomas CR Jr, Waddell TK, Jett JR, Lyss AP, Keller SM, Gandara DR; American College of Surgeons Oncology Group; Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; North Central Cancer Treatment Group; National Cancer Institute of Canada Clinical Trials Group; Southwest Oncology Group.

Ann Thorac Surg. 2014 Aug;98(2):402-10. doi: 10.1016/j.athoracsur.2014.04.129. Epub 2014 Jun 28.

31.

Invasive and noninvasive advances in the staging of lung cancer.

Maldonado F, Jett JR.

Semin Oncol. 2014 Feb;41(1):17-27. doi: 10.1053/j.seminoncol.2013.12.005. Epub 2013 Dec 12. Review.

PMID:
24565578
32.

Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice.

Jett JR, Peek LJ, Fredericks L, Jewell W, Pingleton WW, Robertson JF.

Lung Cancer. 2014 Jan;83(1):51-5. doi: 10.1016/j.lungcan.2013.10.008. Epub 2013 Oct 22.

33.

Screening for lung cancer with low-dose CT scans.

Jett JR.

Respir Investig. 2013 Dec;51(4):205-6. doi: 10.1016/j.resinv.2013.10.001. Epub 2013 Oct 22. No abstract available.

34.

Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.

Voss JS, Iqbal S, Jenkins SM, Henry MR, Clayton AC, Jett JR, Kipp BR, Halling KC, Maldonado F.

Hum Pathol. 2014 Jan;45(1):41-7. doi: 10.1016/j.humpath.2013.07.038. Epub 2013 Oct 16.

PMID:
24139213
35.

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.

Goss GD, O'Callaghan C, Lorimer I, Tsao MS, Masters GA, Jett J, Edelman MJ, Lilenbaum R, Choy H, Khuri F, Pisters K, Gandara D, Kernstine K, Butts C, Noble J, Hensing TA, Rowland K, Schiller J, Ding K, Shepherd FA.

J Clin Oncol. 2013 Sep 20;31(27):3320-6. doi: 10.1200/JCO.2013.51.1816. Epub 2013 Aug 26.

36.

Screening for lung cancer: the US studies.

Midthun DE, Jett JR.

J Surg Oncol. 2013 Oct;108(5):275-9. doi: 10.1002/jso.23391. Epub 2013 Aug 5. Review.

PMID:
23918530
37.

Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.

Kumar SK, Jett J, Marks R, Richardson R, Quevedo F, Moynihan T, Croghan G, Markovic SN, Bible KC, Qin R, Tan A, Molina J, Kaufmann SH, Erlichman C, Adjei AA.

Invest New Drugs. 2013 Oct;31(5):1201-6. doi: 10.1007/s10637-013-0004-2. Epub 2013 Jul 26.

38.

Targeted therapy for non-small cell lung cancer.

Jett JR, Carr LL.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):907-12. doi: 10.1164/rccm.201301-0189PP. Review.

PMID:
23721055
39.

Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Jett JR, Schild SE, Kesler KA, Kalemkerian GP.

Chest. 2013 May;143(5 Suppl):e400S-e419S. doi: 10.1378/chest.12-2363.

PMID:
23649448
40.

Systemic treatment of advanced lung carcinoid tumors: show me the data!

Jett JR, Carr LL.

Chest. 2013 Apr;143(4):884-886. doi: 10.1378/chest.12-2455. No abstract available.

PMID:
23546476
41.

Measurement of electron transfer through cytochrome P450 protein on nanopillars and the effect of bound substrates.

Jett JE, Lederman D, Wollenberg LA, Li D, Flora DR, Bostick CD, Tracy TS, Gannett PM.

J Am Chem Soc. 2013 Mar 13;135(10):3834-40. doi: 10.1021/ja309104g. Epub 2013 Mar 4.

42.

Randomized phase II trial of sulindac for lung cancer chemoprevention.

Limburg PJ, Mandrekar SJ, Aubry MC, Ziegler KL, Zhang J, Yi JE, Henry M, Tazelaar HD, Lam S, McWilliams A, Midthun DE, Edell ES, Rickman OB, Mazzone P, Tockman M, Beamis JF, Lamb C, Simoff M, Loprinzi C, Szabo E, Jett J; Cancer Prevention Network.

Lung Cancer. 2013 Mar;79(3):254-61. doi: 10.1016/j.lungcan.2012.11.011. Epub 2012 Dec 20.

43.

Screening for lung cancer: Who should be screened?

Jett J.

Arch Pathol Lab Med. 2012 Dec;136(12):1511-4. doi: 10.5858/arpa.2012-0259-RA.

PMID:
23194043
44.

Too much of a good thing: blocking noradrenergic facilitation in medial prefrontal cortex prevents the detrimental effects of chronic stress on cognition.

Jett JD, Morilak DA.

Neuropsychopharmacology. 2013 Mar;38(4):585-95. doi: 10.1038/npp.2012.216. Epub 2012 Nov 7.

45.

Src binds cortactin through an SH2 domain cystine-mediated linkage.

Evans JV, Ammer AG, Jett JE, Bolcato CA, Breaux JC, Martin KH, Culp MV, Gannett PM, Weed SA.

J Cell Sci. 2012 Dec 15;125(Pt 24):6185-97. doi: 10.1242/jcs.121046. Epub 2012 Oct 24.

46.

Selective filling of nanowells in nanowell arrays fabricated using polystyrene nanosphere lithography with cytochrome P450 enzymes.

Wollenberg LA, Jett JE, Wu Y, Flora DR, Wu N, Tracy TS, Gannett PM.

Nanotechnology. 2012 Sep 28;23(38):385101. doi: 10.1088/0957-4484/23/38/385101. Epub 2012 Sep 4.

47.

Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.

Reungwetwattana T, Molina JR, Mandrekar SJ, Allen-Ziegler K, Rowland KM, Reuter NF, Luyun RF, Dy GK, Marks RS, Schild SE, Jett JR, Adjei AA.

J Thorac Oncol. 2012 May;7(5):919-22. doi: 10.1097/JTO.0b013e31824de0d6.

48.

Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations.

Yatabe Y, Pao W, Jett JR.

J Thorac Oncol. 2012 May;7(5):775-6. doi: 10.1097/JTO.0b013e318251980b. No abstract available.

49.

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ.

J Thorac Cardiovasc Surg. 2012 Jul;144(1):33-8. doi: 10.1016/j.jtcvs.2012.05.060.

50.

Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.

Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Sugarbaker DJ, Swanson SJ, Travis WD, Jaklitsch MT.

J Thorac Cardiovasc Surg. 2012 Jul;144(1):25-32. doi: 10.1016/j.jtcvs.2012.05.059.

Supplemental Content

Support Center